Skiplinks

Medicine put to the test

As an independent scientific institute, IQWiG examines the benefits and harms of medical interventions for patients. We provide information about the advantages and disadvantages of examination and treatment methods in the form of scientific reports and easily understandable health information.

Latest news

Press Releases

Press Releases

Knowing what helps: “Topic check medicine” starts at IQWiG

2016-07-19 In the “Topic check medicine” members of the public can now propose their topics for an assessment of medical interventions and technologies (health technology assessment, HTA).  read more Link to "Knowing what helps: “Topic check medicine” starts at IQWiG"

Guideline implementation: best practice model for Germany still lacking

2016-07-05 How effective certain measures are cannot be reliably assessed on the basis of study data. But local applicability, user training, and reminder systems could be beneficial.  read more Link to "Guideline implementation: best practice model for Germany still lacking "

Ticagrelor for prevention after myocardial infarction: indication of minor added benefit

2016-07-01 In high risk of developing atherothrombotic events, ticagrelor in combination with low-dose acetylsalicylic acid is now also approved if the infarction occurred more than a year ago.  read more Link to "Ticagrelor for prevention after myocardial infarction: indication of minor added benefit"

Necitumumab in NSCLC: indication of minor added benefit for patients with metastases

2016-07-01 In metastatic NSCLC, there is an advantage in overall survival as well as disadvantages in side effects. No conclusions are possible on locally advanced non-metastatic NSCLC.  read more Link to "Necitumumab in NSCLC: indication of minor added benefit for patients with metastases"

Idelalisib in second-line treatment for CLL: added benefit again not proven

2016-07-01 Since the first G-BA decision was time-limited, a new assessment was required – under changed circumstances: Following severe complications, the therapeutic indication had been restricted.  read more Link to "Idelalisib in second-line treatment for CLL: added benefit again not proven"

loading …

Current commenting procedures (Hearings)

Current commenting procedures (Hearings)

No. Title Type Deadline
N14-04 Procedure for lung volume reduction in severe lung emphysema on the preliminary report 2016-08-05

Commissions advertised

Commissions advertised

Currently no commissions advertised.


Easily understandable information for patients and the general community

Joint aspiration

Joint aspiration involves using a thin hollow needle to take some of the fluid out of the joint. Aspiration is one of the most common procedures used for muscle and bone diseases.  read more (Link to "Joint aspiration" – opens in a new window)

to top

Glossary entries